Klarlund J K, Latini S, Forchhammer J
Fibiger Institute, Danish Cancer Society, Copenhagen, Denmark.
Biochim Biophys Acta. 1988 Aug 19;971(1):112-20. doi: 10.1016/0167-4889(88)90167-x.
A monoclonal antibody that can immunoprecipitate proteins containing phosphotyrosine has been isolated and characterized. To identify proteins that can act as substrates for tyrosine kinases in intact cells, extracts of phosphate-labeled NIH cells that had been treated with the phosphotyrosyl phosphatase inhibitor, vanadate, were precipitated with the antibody, and the immunoprecipitates were analyzed by two-dimensional gel electrophoresis. Numerous proteins were specifically precipitated from vanadate-treated NIH 3T3 cells by the antibody. The high level of phosphotyrosine detected in vanadate-treated cells is presumably primarily due to phosphatase inhibition, but approx. 2-fold increased tyrosine kinase activities were also detected in extracts of the cells after treatment with vanadate. The enhanced tyrosine kinase activity may contribute to the generation of the transformed phenotype seen in response to treatment with vanadate.
一种能够免疫沉淀含磷酸酪氨酸蛋白的单克隆抗体已被分离和鉴定。为了鉴定完整细胞中可作为酪氨酸激酶底物的蛋白质,用磷酸酪氨酸磷酸酶抑制剂钒酸盐处理过的磷酸盐标记的NIH细胞提取物,用该抗体进行沉淀,然后通过二维凝胶电泳分析免疫沉淀物。该抗体从经钒酸盐处理的NIH 3T3细胞中特异性沉淀出许多蛋白质。在经钒酸盐处理的细胞中检测到的高水平磷酸酪氨酸大概主要是由于磷酸酶受到抑制,但在用钒酸盐处理后的细胞提取物中也检测到酪氨酸激酶活性大约增加了2倍。酪氨酸激酶活性的增强可能有助于产生在用钒酸盐处理后所观察到的转化表型。